BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2167324)

  • 21. Platelet function in thrombosis and atherosclerosis.
    Colman RW
    Adv Exp Med Biol; 1978; 104():421-36. PubMed ID: 213955
    [No Abstract]   [Full Text] [Related]  

  • 22. Cyclic AMP signal transduction in posttraumatic stress disorder.
    Lerer B; Ebstein RP; Shestatsky M; Shemesh Z; Greenberg D
    Am J Psychiatry; 1987 Oct; 144(10):1324-7. PubMed ID: 2821835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of action of vitamin E on platelet function.
    Steiner M; Mower R
    Ann N Y Acad Sci; 1982; 393():289-99. PubMed ID: 6293365
    [No Abstract]   [Full Text] [Related]  

  • 24. Synthesis and degradation of cyclic 3',5'-adenosine monophosphate in frog erythrocytes.
    Rosen OM; Goren EN; Erlichman J; Rosen SM
    Adv Biochem Psychopharmacol; 1970; 3():31-50. PubMed ID: 4331461
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cyclic adenosine monophosphate, prostaglandin E and aggregation of blood platelets in man].
    Ardelt W
    Fortschr Med; 1977 Feb; 95(6):366-70. PubMed ID: 190100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenylate cyclase activity in normal and leukemic human leukocytes as determined by a radioimmunoassay for cyclic AMP.
    Polgar P; Vera JC; Kelley PR; Rutenburg AM
    Biochim Biophys Acta; 1973 Feb; 297(2):378-83. PubMed ID: 4350264
    [No Abstract]   [Full Text] [Related]  

  • 27. Arg60 Leu mutation in the first cytoplasmic loop of the platelet thromboxane A2 receptor is not essential for mediating inhibitory coupling between the receptor and adenylyl cyclase.
    Fuse I; Higuchi W; Aizawa Y
    Acta Haematol; 2000; 104(2-3):95-8. PubMed ID: 11154981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of ilexonin A on cAMP metabolism in platelets.
    Wang Z; Li F
    Chin Med Sci J; 1993 Dec; 8(4):215-7. PubMed ID: 8032067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of heparin and dihydroergotamine on platelet adenosine-3',5'-cyclic monophosphate.
    Zahavi M; Welzel D; Wolf H; Honey A; Kakkar VV
    Arzneimittelforschung; 1987 Jun; 37(6):669-74. PubMed ID: 2822055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A simple assay for adenylate cyclase in intact cells by affinity elution chromatography.
    Sinha AK; Colman RW
    Biochem J; 1978 Sep; 174(3):699-702. PubMed ID: 215121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of human platelet adenylate cyclase by collagen fibres. Effect of collagen is additive with that of adrenaline, but interactive with that of thrombin.
    Farndale RW; Winkler AB; Martin BR; Barnes MJ
    Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):25-32. PubMed ID: 1311555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Demonstration of 2 compartments of cyclic AMP in suspensions of human platelets].
    Dechavanne M; Lagarde M
    Pathol Biol (Paris); 1974 Nov; 22 suppl():17-21. PubMed ID: 4377777
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of alpha 2-adrenoceptor agonists and of related compounds on aggregation of, and on adenylate cyclase activity in, human platelets.
    Clare KA; Scrutton MC; Thompson NT
    Br J Pharmacol; 1984 Jun; 82(2):467-76. PubMed ID: 6145472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of a controlled physical load on the level of cyclic adenosine monophosphate in plasma and thrombocytes].
    Volkov VI; Ladnyĭ AI; Tseluĭko VI; Ermakovich II
    Vrach Delo; 1989 May; (5):14-7. PubMed ID: 2549729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphism of cyclic 3',5'-adenosine monophosphate stimulation in rat erythrocytes.
    Stolc V
    Acta Haematol; 1991; 85(4):195-8. PubMed ID: 1713012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
    Merritt JE; Hallam TJ; Brown AM; Boyfield I; Cooper DG; Hickey DM; Jaxa-Chamiec AA; Kaumann AJ; Keen M; Kelly E
    Br J Pharmacol; 1991 Jan; 102(1):251-9. PubMed ID: 1710526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Receptor-specific threshold effects of cyclic AMP are involved in the regulation of enzyme release and superoxide production from human neutrophils.
    Lad PM; Goldberg BJ; Smiley PA; Olson CV
    Biochim Biophys Acta; 1985 Aug; 846(2):286-95. PubMed ID: 2411298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Intracellular actions of antiplatelet drugs which affect cyclic AMP metabolism in platelets--their effects on Ca2+ mobilization and protein phosphorylation in human platelets].
    Nishikawa M; Saitoh M; Deguchi K; Shirakawa S
    Rinsho Byori; 1990 Jul; Suppl 86():54-61. PubMed ID: 2172597
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets.
    Williams KA; Murphy W; Haslam RJ
    Biochem J; 1987 May; 243(3):667-78. PubMed ID: 2444206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High concentrations of exogenous arachidonate inhibit calcium mobilization in platelets by stimulation of adenylate cyclase.
    Kowalska MA; Rao AK; Disa J
    Biochem J; 1988 Jul; 253(1):255-62. PubMed ID: 2458717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.